He J - Search Results

1

Effects of weight loss and physical activity on muscle lipid content and droplet size.

He J, Goodpaster BH, Kelley DE. He J, et al. Obes Res. 2004 May;12(5):761-9. doi: 10.1038/oby.2004.92. Obes Res. 2004. PMID: 15166296 Free article.

2

Exercise training increases intramyocellular lipid and oxidative capacity in older adults.

Pruchnic R, Katsiaras A, He J, Kelley DE, Winters C, Goodpaster BH. Pruchnic R, et al. Among authors: he j. Am J Physiol Endocrinol Metab. 2004 Nov;287(5):E857-62. doi: 10.1152/ajpendo.00459.2003. Epub 2004 Jun 29. Am J Physiol Endocrinol Metab. 2004. PMID: 15226098 Free article. Clinical Trial.

3

Muscle glycogen content in type 2 diabetes mellitus.

He J, Kelley DE. He J, et al. Am J Physiol Endocrinol Metab. 2004 Nov;287(5):E1002-7. doi: 10.1152/ajpendo.00015.2004. Epub 2004 Jul 13. Am J Physiol Endocrinol Metab. 2004. PMID: 15251866 Free article. Clinical Trial.

4

Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes.

Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE. Ritov VB, et al. Among authors: he j. Diabetes. 2005 Jan;54(1):8-14. doi: 10.2337/diabetes.54.1.8. Diabetes. 2005. PMID: 15616005

5

Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content.

Goodpaster BH, Kelley DE, Thaete FL, He J, Ross R. Goodpaster BH, et al. Among authors: he j. J Appl Physiol (1985). 2000 Jul;89(1):104-10. doi: 10.1152/jappl.2000.89.1.104. J Appl Physiol (1985). 2000. PMID: 10904041 Free article.

6

Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity.

He J, Watkins S, Kelley DE. He J, et al. Diabetes. 2001 Apr;50(4):817-23. doi: 10.2337/diabetes.50.4.817. Diabetes. 2001. PMID: 11289047

7

Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes.

Goodpaster BH, He J, Watkins S, Kelley DE. Goodpaster BH, et al. Among authors: he j. J Clin Endocrinol Metab. 2001 Dec;86(12):5755-61. doi: 10.1210/jcem.86.12.8075. J Clin Endocrinol Metab. 2001. PMID: 11739435

8

Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes.

Kelley DE, He J, Menshikova EV, Ritov VB. Kelley DE, et al. Among authors: he j. Diabetes. 2002 Oct;51(10):2944-50. doi: 10.2337/diabetes.51.10.2944. Diabetes. 2002. PMID: 12351431

9

Gene therapy for type 1 diabetes: is it ready for the clinic?

D'Anneo A, Rood P, Bottino R, Balamurugan AN, He J, Giannoukakis N. D'Anneo A, et al. Among authors: he j. Immunol Res. 2006;36(1-3):83-9. doi: 10.1385/IR:36:1:83. Immunol Res. 2006. PMID: 17337769 Review.

10

Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-kappaB activation in vascular smooth muscle cells.

Cifarelli V, Luppi P, Tse HM, He J, Piganelli J, Trucco M. Cifarelli V, et al. Among authors: he j. Atherosclerosis. 2008 Dec;201(2):248-57. doi: 10.1016/j.atherosclerosis.2007.12.060. Epub 2008 Feb 21. Atherosclerosis. 2008. PMID: 18294642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,450 results

Search Page

Filters